trending Market Intelligence /marketintelligence/en/news-insights/trending/jInd2dMCQ-UdSa-lGPVi0g2 content esgSubNav
In This List

DuPont lifts 2019 pro forma adjusted EPS outlook as adjusted EPS beats estimates

Case Study

Case Study: Alternative Investment Funds Scorecard

Blog

Anticipate the Unknown by Marrying Award-Winning Data with Cutting-Edge Credit Models

Blog

Automating Credit Risk Management: A Bank’s View

Blog

Corporate Credit Risk: Macroeconomic Recovery Projections Post-COVID-19


DuPont lifts 2019 pro forma adjusted EPS outlook as adjusted EPS beats estimates

DuPont de Nemours Inc. lifted its 2019 pro forma adjusted EPS guidance after the second-quarter adjusted EPS surpassed analyst expectations.

The company booked a net loss attributable to DuPont common stockholders of $571 million, or 76 cents per share, in the second quarter ended June 30, compared with attributable net income of $1.77 billion, or $2.27 per share, in the year-earlier period.

Adjusted net income rose 4% year over year to $725 million, or 97 cents per share, from $695 million, or 89 cents per share reported in the year-ago period. The S&P Global Market Intelligence consensus normalized EPS estimate for the second quarter was 82 cents.

Net sales fell 7% year over year to $5.47 billion from $5.86 billion amid lower autobuilds and weaker electronics demand in the transportation and industrial division as well as currency headwinds across all divisions.

Meanwhile, cost of sales fell 14% to $3.50 billion from $4.09 billion.

DuPont said it raised its full-year 2019 pro forma adjusted EPS to $3.75 to $3.85 but slightly lowered its organic growth outlook compared with the prior year.

The company's net loss from continuing operations came in at $1.10 billion, or $1.48 per share, primarily affected by a pretax goodwill impairment charge of $1.18 billion.

In May, the company said it expected to book a pretax goodwill impairment charge of $800 million to $1.3 billion in the second quarter. This reflected unfavorable market conditions, including a demand slowdown in the biomaterials business and challenging conditions in U.S. bioethanol markets. The impairment charge followed after DowDuPont completed the spinoff of its material sciences division on April 1 as part of its breakup process.

Through June 30, the company's net loss attributable to DuPont common stockholders totaled $50 million, or 7 cents per share, down from attributable net income of $2.86 billion, or $3.69 per share, recorded in the prior-year period.